优先考虑大脑健康_21页_7mb

Summary of Technical Appendix from "Prioritizing Brain Health"

Methodology and Key Assumptions
The report uses the Global Burden of Disease (GBD) data from IHME to estimate the primary and associated disease burden of mental health conditions, quantified in disability-adjusted life years (DALYs). Mental health conditions are defined to include both mental and substance use disorders. Key assumptions involve temporal associations and risk factors, with limitations acknowledged due to incomplete data and the need for further refinement. The analysis is an "art of the possible" approach, estimating potential benefits of scaling interventions.

Primary and Associated Burden of Mental Health Conditions
The primary burden is calculated from IHME data, adjusted for comorbidities and excluding double-counting. Estimated disease burden includes total DALYs for mental health conditions. Associated burden comes from two sources: (1) other non-communicable diseases (NCDs) where substance use is a risk factor, based on global risk factor data from IHME GBD; and (2) preexisting mental health conditions exacerbating other NCDs. PAFs are calculated and applied to non-mental health conditions, with simplifying assumptions due to limited evidence.

Mental Health Improvement Through Scaling Interventions
Interventions are categorized into four groups: environmental and behavioral (e.g., policy regulation, prevention programs); health promotion and prevention (e.g., screening); therapeutic (e.g., medicines and counseling). Effectiveness is derived from clinical guidelines and systematic reviews, with adoption rates based on country income archetypes. Impact is modeled sequentially: behavioral and prevention interventions applied first, followed by therapeutic ones, using an S-shaped ramp-up curve reflecting implementation time. Disease burden reduction is calculated for primary mental health conditions and associated broader NCDs by applying PAFs and effectiveness rates from 2025 to 2050, assuming a direct relationship between intervention uptake and burden reduction.

Impact of Health Improvements on the Economy
Scaling mental health interventions could boost global GDP through supply-side benefits. Key economic gains come from fewer premature deaths (increasing labor force participation), reduced disability and absenteeism, prevention of lost future earnings, and reduced presenteeism. Delayed improvements consider factors like employment recovery after treatment and caregiver releases in high-income countries, with adjustments for country-specific labor market dynamics.

Cost Analysis and Economic Return Calculation Methodology
Cost-effectiveness is assessed using the cost-per-DALY averted, with estimates varying by income level and intervention type (e.g., environmental interventions are lower cost in low-income countries, while therapeutic interventions are higher). Incremental scaling costs are calculated by adjusting DALY costs and adoption rates. Economic return is estimated by dividing the potential GDP boost from health improvements by the investment required, yielding a return ratio based on WHO-CHOICE thresholds. Data limitations mean the analysis provides directional insight but not precise forecasts.

Key Economic Return Findings
The model isolates the impact of scaling interventions from other economic factors by assuming 90% adoption in 2025 and projecting effects through 2050. Preliminary return ratios are derived from GDP uplift comparisons with investment, but these are illustrative due to assumptions about funding priorities and innovation.